Tharimmune (THAR) Stock Rallies After Positive EMA Feedback Boosts Confidence
Fahim Awan
October 30, 2024
Tharimmune, Inc. (NASDAQ: THAR) saw a significant rise in its stock price, climbing by 159.40% to $5.24 after receiving encouraging feedback from the European Medicines